𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Synthesis of [14C] - and [13C6]-labeled tipranavir and its potential hydroxyl metabolite and the glucuronide conjugate

✍ Scribed by Bachir Latli; Matt Hrapchak; John A. Easter; Wayne T. Stolle; Karl Grozinger; Dhileepkumar Krishnamurthy; Chris H. Senanayake

Publisher
John Wiley and Sons
Year
2008
Tongue
French
Weight
185 KB
Volume
51
Category
Article
ISSN
0022-2135

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Tipranavir or Aptivus^®^ is a non‐peptidic protease inhibitor approved for the combination treatment with ritonavir of HIV infection. Tipranavir labeled with radioactive and stable isotopes of carbon was required for drug metabolism (excretion, distribution, and absorption) studies and to develop bioanalytical methods needed for the support of clinical studies. [7‐^14^C]‐Benzoic acid and uniformly labeled benzoic acid (ring‐^13^C~6~ 99 at% ^13^C) were used to prepare [^14^C]‐ and [^13^C~6~]‐labeled tipranavir, respectively. Radioactively labeled tipranavir was prepared with a specific activity of 54 mCi/mmol (2GBq/mmol); it was necessary to dilute its specific activity with unlabeled tipranavir to 28 mCi/mmol (46.45 µCi/mg) because of its instability. The N‐hydroxyl metabolite (12) and the glucuronide conjugate (13), the most abundant metabolites of tipranavir (when administered in conjunction with ritonavir) were also synthesized. Copyright © 2008 John Wiley & Sons, Ltd.

📜 SIMILAR VOLUMES

Synthesis of [14C]-labelled repinotan hy
Synthesis of [14C]-labelled repinotan hydrochloride and its major metabolite M-6
✍ D. Seidel; M. Conrad; Y. Schoof; R. Schohe-Loop 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 150 KB

## Abstract For studies of pharmacokinetics and drug metabolism of the new 5‐HT~1A~ agonist repinotan, the ^14^C‐labelled version was synthesized. Starting from [U‐^14^C]phenol, a 10‐step synthesis led to 457 mg (1.58 GBq) of [U‐^14^C]repinotan hydrochloride, labelled uniformly in the aromatic ring

Synthesis of two 14C-labeled forms of pr
Synthesis of two 14C-labeled forms of prinomide, a potential anti-inflammatory compound and its hydroxy metabolite, labeled with 14C
✍ Naba K. Chaudhuri; Bohdan Markus 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 298 KB

## Abstract The synthesis of two ^14^C‐labeled forms of prinomide, compounds 7 and 10, and the synthesis of a ^14^C‐labeled form of its hydroxy metabolite are described. Compound 7 was synthesized by the reaction of phenyl isocyanate and 1‐methyl‐β‐oxo‐pyrrole‐2‐propanenitrile‐carbonyl‐^14^C (6), w

Synthesis of 2H- and 13C-labelled suniti
Synthesis of 2H- and 13C-labelled sunitinib and its primary metabolite
✍ Paul W. Elsinghorst; Michael Gütschow 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 210 KB

## Abstract Sunitinib (Sutent^®^, Pfizer) was approved in 2006 for the treatment of gastrointestinal and renal cancer. Isotope‐labelled derivatives have already been prepared for PET and ADME radiography. The preparation of ^13^C‐ and ^2^H‐labelled internal standards of sunitinib (SU11248) and its

A short synthesis of [14C]-labelled leva
A short synthesis of [14C]-labelled levamisole and its major metabolite
✍ Cor G.M. Janssen; Jos B.A. Thijssen; Willy L.M. Verluyten 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 109 KB

## Abstract Levamisole (**I**) is the __levo__ isomer of tetramisole. It is a broad spectrum anthelmintic which is used extensively as a veterinary drug for food producing animals. Metabolism and environmental studies necessitated the synthesis of ^14^C‐labelled levamisole (**6**) and of its major

Synthesis of 3H, 14C and 13C6 labelled S
Synthesis of 3H, 14C and 13C6 labelled Sch 58235
✍ D. Hesk; G. Bignan; J. Lee; J. Yang; K. Voronin; C. Magatti; P. McNamara; D. Koh 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 130 KB

## Abstract ^3^H‐Sch 58235 was prepared at a specific activity of 29.1 Ci/mmol by Ir(COD)(Cy~3~P)PyPF~6~ catalysed exchange with tritium gas. ^14^C‐Sch 58235 was prepared in three steps from __p__‐hydroxy[ring‐U‐^14^C]benzaldehyde with an overall radiochemical yield of 21%. ^13^C~6~‐Sch 58235 was s